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Highlights 
 Vaccination campaigns against myxomatosis and rabbit haemorrhagic disease 
(RHD) are commonly used in translocation programs 
 For economic and logistic reasons rabbits are vaccinated without previously 
assessing their immunological status (i.e. blind vaccination campaigns) 
 We tested the efficacy of blind vaccination based on rabbit survival in three 
enclosures where wild rabbits were kept in semi-natural conditions 
 Average monthly survival of vaccinated rabbits did not differ to that of 
unvaccinated individuals 
 Blind vaccination may be mostly ineffective and costly since the adults’ 
prevalence of natural antibodies against these endemic diseases is often expected 
to be high. 
 
 
 
 
A B S T R A C T 
Vaccination campaigns against myxomatosis and rabbit haemorrhagic disease (RHD) 
are commonly used in translocation programs conducted for the purpose of recovering 
wild European rabbit populations in Iberian Mediterranean ecosystems. In most cases 
rabbits are vaccinated ‘blind’ (i.e. without assessing their prior immunological status) 
for economic and logistic reasons. However there is conflicting evidence on the 
effectiveness of such an approach. We tested whether blind vaccination against 
myxomatosis and rabbit haemorrhagic disease improved rabbit survival in a rabbit 
translocation program where wild rabbits were kept in semi-natural conditions in three 
enclosures. We conducted nine capture sessions over two years (2008–2010) and used 
the information collected to compare the survival of vaccinated (n = 511) versus 
unvaccinated (n = 161) adult wild rabbits using capture-mark-recapture analysis. 
Average monthly survival was no different for vaccinated versus unvaccinated 
individuals, both in the period between release and first capture (short-term) and after 
the first capture onward (long-term). Rabbit survival was lower in the short term than in 
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the long term regardless of whether rabbits were vaccinated or not. Lower survival in 
the short-term could be due to the stress induced by the translocation process itself (e.g. 
handling stress). However, we did not find any overall effect of vaccination on survival 
which could be explained by two non-exclusive reasons. First, interference of the 
vaccine with the natural antibodies in the donor population. Due to donor populations 
have high density of rabbits with, likely, high prevalence of antibodies as a result of 
previous natural exposure to these diseases. Second, the lack of severe outbreaks during 
the study period. Based on our findings we argue that blind vaccination of adult rabbits 
in translocation programs may be often mostly ineffective and unnecessarily costly.  
In particular, since outbreaks are hard to predict and vaccination of rabbits with natural 
antibodies is ineffective, it is crucial to assess the immunological status of the donor 
population before translocating adult rabbits. 
 
Key words: mortality, Oryctolagus cuniculus, translocation, disease control, wildlife 
management 
 
 
 
1. Introduction 
In Iberian Mediterranean ecosystems, the European rabbit (Oryctolagus cuniculus) is a 
keystone species that has declined dramatically, with profound implications for 
conservation and management (Delibes-Mateos et al., 2008). The appearance of 
myxomatosis in the 1950s and the arrival of rabbit haemorrhagic disease (RHD) at the 
end of the 1980s caused substantial reductions in rabbit population density (Calvete et 
al., 2002), and the extinction of many local wild populations (Villafuerte et al., 1995; 
Delibes-Mateos et al., 2009). Myxomatosis and RHD are caused by a leporipoxvirus 
and a calicivirus respectively, with both diseases now endemic in the Iberian Peninsula. 
Resulting rabbit population declines are ongoing; for example a new variant of RHD 
(i.e. RHDV2) caused a considerable decrease in wild rabbit numbers in France (2010), 
Spain (2011) and Portugal (2012) (Delibes-Mateos et al., 2014; Le Gall-Reculé et al., 
2013).  
 
Considerable effort has been made in recent decades to reduce mortality from these 
diseases by translocating wild rabbits into areas where wild populations are low or 
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extinct and implementing vaccination campaigns just before release. Indeed, these 
measures are among the most frequent management actions made to stimulate the 
recovery of wild rabbit populations in this region (Angulo and Villafuerte, 2003). In 
most translocation programs, for supposed economic and logistic reasons rabbits are 
vaccinated without previously assessing their immunological status, and additional 
information on sex, heath status or age of the individuals for example, are rarely 
collected (i.e. ‘blind’ vaccination; Cabezas et al., 2006). For the purposes of this paper, 
blind’ vaccination campaigns are defined as vaccinating animals without prior 
knowledge of their immunological status. 
 
The effectiveness of blind vaccination against myxomatosis and RHD has been 
questioned by hunters, conservationists and wildlife managers. Few studies have 
assessed its effectiveness in improving rabbit survival and population recovery 
(Cabezas et al., 2006; Calvete et al., 2004a, 2004b), and the results from those are 
conflicting. Improvements in survival seem to depend on a variety of factors such as 
handling stress, individual physical condition, previous immunological status, and 
population and disease dynamics (Calvete et al., 2004b; Ferreira et al., 2014). 
 
The aim of this case study was to evaluate the effectiveness of a blind vaccination 
campaign against myxomatosis and RHD in improving both short and long-term 
survival of wild adult rabbits kept in semi-natural conditions as part of translocations 
conducted for an endangered predators’ conservation program in southwest Spain.  
 
2. Material and methods 
Ethics statement 
Manipulations of all animals reported in this study were in accordance with Spanish and 
European regulations (Law 32/2007, R.D. 1201/2005 and Council Directive 
2010/63/EU). 
 
Study site, vaccination and data collection 
The study took place in the southwestern Iberian Peninsula (Hornachuelos Natural Park; 
37°49′ N, 5°15′ W; 100–700 m elevational range), where the climate is Mediterranean 
with hot, dry summers and cool, wet winters. We analysed capture-recapture data 
collected during ten capture sessions over two years in three enclosures (E1, E2, E3; 
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about 4 ha each) built as rabbit breeding zones. The enclosures were between 2 and 4 
km apart. Each enclosure was surrounded by a 2.5-m high chain-link fence to exclude 
terrestrial predators (Rouco et al., 2008) and contained 30 regularly distributed artificial 
warrens. Water and pellet food was supplied ad libitum, along with sown grass to 
increase the availability of fresh food. Each warren was built with a capture device 
consisting of a wire net fence with metal cage-traps attached to holes in the fence (see 
Santoro et al. (2014) for a complete description of the study area). 
 
We conducted a standard vaccination campaign for rabbit translocations. Rabbits were 
captured from wild donor populations by trapping or ferreting. Rabbits released in E1 
(in March 2008) and E2 (in April 2008) were from two populations in the municipality 
of Córdoba (one donor population per enclosure), while those released in E3 (in May 
2008) were from a population in Cádiz. Both donor population areas are located in 
southwestern Spain, about 70 and 160 km from the study area respectively. Individuals 
were released into enclosures without quarantine periods, but were confined inside 
warren pens for their first 6 nights (a practice that improves survival; Rouco et al., 
2010). All rabbits released within an enclosure were captured using the same 
methodology and were handled and released under similar conditions. 
 
Randomly selected rabbits were injected subcutaneously just before release into each 
enclosure with commercial vaccines against myxomatosis (live Shope fribroma virus 
Mixohipra-FSA, Hipra Laboratory, Gerona, Spain) and RHD (ARVILAP, Ovejero 
Laboratory, León, Spain), at the doses recommended for domestic rabbits. Only adult 
rabbits were translocated. Ninety-four males (nvaccinated = 71) and 159 females (nvaccinated 
= 121) were released into E1; 56 males (nvaccinated = 44) and 81 females (nvaccinated = 71) 
into E2; 103 males (nvaccinated = 74) and 179 females (nvaccinated = 130) into E3 (Table 1S, 
see supplementary material). 
 
Capture-recapture data was collected from 9 live-trapping recapture sessions following 
the release sessions, from March-June 2008 to April 2010. Captures took place on one 
night only and involved activation of the capture devices at midday, when the rabbits 
were less active and mostly underground. The following morning, the rabbits trapped 
inside the cages were counted and handled (i.e. all animals were weighed, sexed and 
ear-marked with numbered metal tags (Presadom nº3, France). Previous studies have 
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shown that live-trapping in our study area can capture a large proportion of the rabbit 
population (i.e. 50–60% of the population) in only one night (see Santoro et al., 2014). 
All individuals were released at their capture location. Time intervals between capture 
sessions were unequal (Table 1S, see supplementary material), but this was specifically 
accounted for in capture-recapture analyses conducted.  
 
Additionally, from August 2008 to November 2009, in order to determine any outbreak 
of disease, we inspected on a monthly basis each enclosure by walking inside along 20-
30 minutes looking for rabbit carcasses. When possible, causes of death were 
determined by post-mortem examination of rabbit carcasses. Predation was assigned to 
raptors when evidence including feathers, characteristic tufts of torn-out fur, or remains 
of long bones were found. However, rabbits assigned to predation could also be 
scavenged. Diseases was assigned to those rabbits with clear lesions due to 
myxomatosis and/or RHD. Deaths included in the “other causes” category included 
those assigned to handling stress or aggression associated with social interactions 
(Calvete and Estrada 2004; Moreno et al. 2004). 
 
Goodness of fit 
Animals born during the study period were excluded from analyses. To estimate 
survival, and identify its determinants, we performed a capture-recapture analysis which 
provides accurate estimates even when not all alive marked individuals are recaptured 
(Lebreton et al. 1992). Before this analysis we used U-CARE 2.3.2 (Choquet et al., 
2005) to test the goodness of fit of the Cormack–Jolly–Seber (CJS) model (a fully 
parameterized model allowing for time variation in both survival and individual capture 
probabilities). The fit of the CJS model is routinely assessed prior to full analysis since 
an adequate fit indicates that the data is also valid for the set of candidate models (with 
less parameters) used for hypotheses-testing. U-CARE also allows testing for specific 
causes of lack of fit such as trap-dependence (i.e. individual capture probability 
depending on whether it was captured or not in the previous session). A goodness of fit 
analysis was performed separately for each population (E1–E3).  
 
Capture-recapture analyses 
At all trapping sessions, a number of randomly selected individuals (Ntotal: E1 = 24, E2 
= 32 and E3 = 27) were removed just after being captured and translocated into nearby 
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areas as a part of the ongoing translocation program. Removals were coded in the data 
sets and do not affect estimation of parameters nor should they bias survival estimates 
as the removed individuals were chosen randomly. 
 
Due to logistic constraints, capture–recapture sessions were not synchronised among the 
three enclosures (E1–E3) (Table 1S, see supplementary material). Furthermore, each 
enclosure differed in donor population, stocking date and population size. We thus 
modeled the data from each enclosure separately. Survival was estimated as a monthly 
rate; for each enclosure we estimated and tested the effect on survival rate of: (i) 
vaccination status (vaccinated vs. unvaccinated), (ii) sex, and (iii) short-term versus 
long term effects. Short-term refers to survival between initial release and the first 
recapture session (e.g. that might be affected by translocation stress), and long-term 
refers to average survival from the first recapture session to the end of the study. With a 
focus on survival response to vaccination, we also considered the interaction between 
vaccination status and time after release (i.e. the short- and long-term survival of 
vaccinated and unvaccinated rabbits). 
 
Analyses were performed in MARK 7.2 (White and Burnham, 1999). Following the 
notation used in Lebreton et al. (1992), the global starting model was defined as (vac x rel 
x sex psex x time) which means that survival (ϕ) is left to vary according to the interaction of 
vaccination status, short- and long-term from release (rel) and sex, while capture 
probability (p) varies according to sex and time (i.e. different for each capture session). 
Importantly, fences prevented emigration of individuals from each enclosure. This is 
important because it allowed us to obtain true survival estimates that uniquely depend 
on mortality and not on the dispersal process. Model selection of candidate models was 
based on the Akaike Information Criterion corrected for sample size (AICc; Burnham 
and Anderson, 2002). If a model accounting for an effect of vaccination appeared to 
have substantial support (AICc - AICc min ≤ 2; Burnham and Anderson, 2002), we 
used the Likelihood Ratio Test (LRT) against the nested model without vaccination to 
assess the significance of the vaccination effect. 
 
For each enclosure separately, we first modeled covariates affecting individual 
probabilities of recapture, and then held the lowest AICc model structure for recapture 
probability and modeled survival probabilities. Survival estimates were calculated as 
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averages from the entire set of candidate models,  to minimize any potential effect of 
model selection uncertainty (Burnham and Anderson, 2002). 
 
3. Results 
Goodness of fit 
No lack of fit was detected for the CJS model for the mark-recapture data from each of 
the three enclosures (E1: χ2[24] = 18.77, p = 0.76, Signed Statistic for Trap-Dependence 
(SSTD) = -1.38, p = 0.17; E2: χ2[21] = 5.07, p = 0.99, SSTD = -1.23, p = 0.22; E3: χ2[40] = 
19.70, p = 0.99, SSTD = -1.23, p = 0.22).  
 
Capture-recapture estimates 
According to the AICc model rankings for enclosures E2 and E3, we cannot discard a 
positive effect of vaccination on long-term rabbit survival (Table 1, models within 2 
AICc are equally plausible). However, this effect was not included in plausible models 
for enclosure E1, and its magnitude was so small that it was statistically insignificant in 
all three enclosures (as calculated by Likelihood Ratio Tests; E1, PLRT = 0.42; E2, PLRT 
= 0.26; E3, PLRT = 0.09). Overall, the probability of rabbit monthly survival was greater 
in the long-term than it was in the short-term (the period immediately after 
translocation). We also detected differences in survival between males and females 
(Table 1), but they varied in magnitude and direction among enclosures (Fig. 1). 
 
Dead rabbits 
The causes of death and the number of dead rabbits found during the study period 
varied between enclosures (Figure 1S, see supplementary material). Out of 167 rabbit 
carcasses collected during the study period (E1=50, E2=78 and E3=89), 8 in E1 (16%), 
33 in E2 (42%) and 22 in E3 (25%) were assigned to diseases. Most of the carcasses 
were collected during 2009. Those found between August and September 2009 had 
clear lesions due to myxomatosis, and those found in November 2009 were assigned to 
RHD. 
 
4. Discussion 
Our results revealed that a blind vaccination campaign of adult wild rabbits did not 
consistently improve their survival. Rather the only consistent difference observed in 
our study was that rabbit survival was lower in the short term than in the long term 
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regardless of whether rabbits were vaccinated or not (Fig. 1). This could likely be due to 
the stress that translocations programs generates to the target species (Teixeira et al., 
2007). Survival was also dependent on time period and sex, but with the direction of 
differences varying among enclosures. Females survived better in E1 and E2, but not in 
E3. This could be due to the different timing of the translocations into the enclosures, 
since in E3 rabbits were released in May just after the peak of the breeding season. The 
accumulated stress of translocation plus depletion of body condition due to breeding 
(Kontsiotis et al., 2014) might have caused a reduction in female survival in that 
enclosure. 
 
There was no detrimental effect of vaccination on short- or long-term rabbit survival 
(Fig. 1), but neither did we find clear support for beneficial effects. One possible 
explanation for why blind vaccination may have been ineffective for adult rabbits would 
be a high prevalence of natural antibodies against myxomatosis and RHD in the test 
population, analogous to what has been suggested for the RHD vaccination in the 
Iberian peninsula (Cotilla et al., 2010). Wild populations of rabbits are characterised by 
age-dependent increases in the prevalence of antibodies to myxomatosis and RHD 
(Calvete et al., 2002; Cooke et al., 2000), which may interfere with immunisation by 
vaccination, neutralising its effect on adult wild rabbit survival (Cabezas et al., 2006; 
Calvete et al., 2004a). Unfortunately, due to logistic constrains, we could not determine 
the immunological status of the donor population. However, the Andalusian 
Government released a public report in August 2012 showing that prevalence of 
antibodies against myxomatosis in 2009 was 59.3% and 61.4% for the Cordoba and 
Cadiz regions respectively (Junta-de-Andalucía, 2012). These values were similar to 
those obtained in the study site in 2009 by the new born animals in the enclosures for 
myxomatosis (~50% prevalence of antibodies) but slightly lower for RHD (~25% 
prevalence of antibodies) (Bertó-Moran et al., 2013). However, antibodies may not 
always be protective, especially in the case of RHD. For example, antibodies from non-
pathogenic caliciviruses did not guarantee complete protection against RHD virus (Le 
Gall-Reculé et al., 2011). The same has been observed for RHD virus antibodies and the 
recently emerged variant RHDV2 (Le Gall-Reculé et al., 2013). However, it seems that 
infection with non-pathogenic caliciviruses does not cause significant interference with 
the diagnostic value of RHD infection using commercial enzyme-linked immunosorbent 
assay, cELISA (Zheng and Parkes, 2011). Moreover, such non-pathogenic viruses have 
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not been isolated yet in Spain. Therefore, in the absence of further information we could 
assume that most cases of RHD antibodies in Spanish wild rabbit reflect activity of 
virulent RHD virus (Cotilla et al., 2010). 
 
Blood antibodies concentration can decrease naturally over time when there is absence 
of the viruses within a population (Mutze et al., 2002). This will suggest that apparently 
there is no long-term advantage of primary vaccination, and therefore it would be 
necessary to carry out periodic vaccination campaigns. Something difficult to achieve in 
the field because of the logistic and economics constrains. The time of vaccination is 
important (Guitton et al., 2008) and since the time of epidemics varies from one year to 
another, this would require the establishment of a health monitoring program of wild 
rabbit populations. 
 
Outbreaks of myxomatosis and RHD occurred in our study enclosures between July-
September 2009 and November 2009, respectively (Fig. 1S, see supplementary 
material). Based on the number of carcasses found during 2009, such outbreaks did not 
seem to be severe, which could partially explain the lack of significant increase in rabbit 
survival associated with double vaccination against these diseases. 
 
Lack of effectiveness of double vaccination against myxomatosis and RHD is in 
agreement with two previous studies (Calvete et al., 2004a, 2004b). A considerable 
amount of information exists on the mechanisms through which vaccination against 
myxomatosis and RHD affects survival of wild translocated rabbits. In addition to the 
stress caused by the translocation process itself (e.g. capture, new area, etc.), the 
handling of vaccinated rabbits can be detrimental for survival especially for individuals 
in poor-condition (Cabezas et al., 2006) and juveniles (Calvete et al., 2004b). 
Vaccination campaigns in the field can additionally be influenced by the highly variable 
spatial-temporal pattern exhibited by the causative viruses (Villafuerte et al., 2000), 
which is a function of a panoply of factors such as the virulence of circulating strains or 
population density (Calvete, 2006; Ferreira et al., 2009), age (Calvete et al., 2004a, 
2004b), timing of vaccination with respect to disease outbreaks (Calvete, 2006; Ferreira 
et al., 2009), body condition (Cabezas et al., 2006), and habitat management practices 
(Ferreira et al., 2014).  
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Our results suggest that care has to be taken before establishing a vaccination protocol 
in translocated rabbits against myxomatosis and RHD. In fact, the circumstances under 
which it is undertaken in the field by game managers and/or conservationists can be 
quite different between locations or seasons generating huge uncertainty in the possible 
outcomes. Given the impact of both diseases on rabbit survival, if it is not feasible to 
assess the immunological status of the donor population, the most conservative option is 
to carry out blind vaccination campaigns to ensure that translocated rabbits are at least 
protected against infection (or disease) after release, particularly if juveniles are being 
translocated since they generally have lower antibody prevalence (Guitton et al., 2008). 
However, particularly when adults are being moved as in the present study case, our 
results indicate that blind double vaccination may increase the economic cost without 
any benefit of significantly increased survival. We therefore recommend that game 
managers and conservationists carefully consider the cost/benefit trade-off of 
implementing vaccination as a management policy in rabbit translocations.  
 
5. Conclusion 
In particular, we recommend to assess the immunological status of the donor population 
prior to translocations since, if the prevalence of natural antibodies against these 
diseases is high, vaccination may be worthless especially when adult rabbits are moved. 
Such assessments should be performed just before the translocation, since natural 
antibody prevalence against myxomatosis and RHD varies independently among years, 
populations, ages and sexes (Arenas et al., 2012; Parkes et al., 2008; Santoro et al., 
2014). 
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Figure captions 
 
Fig 1. Model averaged monthly survival estimates (±95% CI) in the three study areas 
(E1–3), of females (A) and males (B). Full and empty symbols indicate vaccinated and 
non-vaccinated rabbits, respectively. Triangles correspond to survival estimates in the 
interval just after release (i.e. short-term). Circles correspond to average survival 
through subsequent intervals (i.e. long-term). 
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Tables 
Table 1. Ranking of possible models for rabbit survival based on the Aikaike Information Criterion corrected for small sample size. 
Area Model effects AICc AICc AICc w Np Dev 
 sex x rel 1278.26 0.00 0.47 13 307.34 
 sex x (short x vac + long) 1280.58 2.33 0.15 15 305.62 
 sex x (short + long x vac) 1280.86 2.61 0.13 15 305.90 
 Rel 1281.02 2.76 0.12 11 314.14 
E1 rel x vac 1281.52 3.26 0.09 13 310.61 
 sex x rel x vac 1282.73 4.47 0.05 17 303.72 
 Sex 1316.26 38.01 0.00 11 349.39 
 sex x vac 1320.20 41.94 0.00 13 349.29 
 Constant 1322.45 44.19 0.00 10 357.60 
 Vac 1324.46 46.20 0.00 11 357.59 
       
 sex x rel 778.61 0.00 0.53 13 304.94 
 sex x (short + long x vac) 780.03 1.42 0.26 15 302.28 
 sex x (short x vac + long) 781.48 2.87 0.13 15 303.73 
 sex x rel x vac 783.17 4.56 0.05 17 301.32 
E2 rel 785.49 6.88 0.02 11 315.89 
 rel x vac 786.07 7.46 0.01 13 312.40 
 sex 798.06 19.45 0.00 11 328.46 
 sex x vac 798.79 20.18 0.00 11 329.19 
 vac 798.79 20.18 0.00 11 329.19 
 constant 801.31 22.70 0.00 10 333.74 
       
 sex x (short + long x vac) 1587.11 0.00 0.40 15 476.03 
 sex x rel 1587.75 0.64 0.29 13 480.76 
 sex x rel x vac 1589.02 1.92 0.15 17 473.85 
 sex x (short x vac + long) 1589.11 2.01 0.15 15 478.04 
E3 rel 1608.46 21.35 0.00 11 505.54 
 rel x vac 1609.48 22.37 0.00 13 502.48 
 sex x vac 1612.00 24.89 0.00 13 505.01 
 sex 1613.32 26.21 0.00 11 510.40 
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 vac 1620.90 33.80 0.00 11 517.98 
 constant 1621.77 34.67 0.00 10 520.89 
All the final models shown here were parameterized according to previous model selection made on capture probability (see Methods for details). Accordingly, capture probability was hold as 
varying through capture sessions (time) in E1 and E2 and both through capture sessions and for each sex (time and sex) in E3. In bold are shown the more parsimonious models according to the 
correspondent AICc ranking (AICc<2). Notation: AICc, Akaike information criterion corrected for small sample size; ΔAICc, the difference in AICc between the current model and the lowest 
AICc value; AICc w, Akaike’s weight; np, number of estimable parameters; Dev, relative deviance; sex, sex; short, first interval after release, long, pooled intervals subsequent to the first capture 
session after release, rel, two periods corresponding to both short and long, and vac, vaccination status (vaccinated vs. unvaccinated). 
 
